Noerr advises M4Capital on financing round for cannabis company Bloomwell

Noerr has advised venture capital investor M4Capital on the seed financing for Frankfurt-based start-up Bloomwell Group. This transaction, which is worth over ten million US dollars, marks the highest officially known seed investment for a European cannabis company to date.

In addition to Munich-based early-stage digital health investor M4Capital, the US growth capital provider Measure 8 Venture Partners also participated in the financing round. Bloomwell Group acts as a holding company for medical cannabis companies as well as potentially for companies in possible future legal cannabis markets. Bloomwell’s goal is to build, acquire and invest in ESG healthcare companies along the entire value chain, with the exception of cultivation. Bloomwell also owns Algea Care, the leading European telemedicine company for medical cannabis.

Noerr is one of the leading law firms in the field of private equity and venture capital and advises investors and growth companies on financing or acquiring businesses, developing and expanding portfolio companies, reorganising and divesting companies, as well as on structuring and establishing private equity funds and investment vehicles. This year, for example, Noerr advised Deutsche Börse on the agreement of a strategic partnership with Commerzbank and an investment in 360X AG as well as US tech investor Dragoneer Investment Group on a growth stage financing round for neo-bank N26.

Advisors to M4Capital GmbH: Noerr Partnerschaftsgesellschaft mbB

Holger H. Ebersberger, Julia Hecht (both Private Equity & Venture Capital, Munich)